SAN DIEGO, — Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that it has received a milestone payment from Ipsogen S.A., a subsidiary of the QIAGEN group. This payment comes from a co-exclusive license agreement to manufacture and sell diagnostic kits for the detection of nucleophosmin protein (NPM1) mutations in patients […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its wholly-owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed several international distribution agreements that will expand access to the MaterniT21 PLUS testing service outside the United States. Agreements in […]
Transgenomic Acquires ScoliScore™ Adolescent Idiopathic Scoliosis Prognostic Test from Axial Biotech
OMAHA, Neb. – Transgenomic, Inc. (OTCBB: TBIO) announced today that it has entered into a definitive agreement to acquire the global rights to Axial Biotech’s ScoliScore™ Adolescent Idiopathic Scoliosis (AIS) Prognostic Test for a total consideration of $4.4 million in cash. The acquisition provides Transgenomic with the ScoliScore™ assay technology and intellectual property, an established […]
Milford, Mass., – SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, has expanded its performance panel product offerings. SeraCare’s third Worldwide HCV RNA Performance Panel and eighth Anti-HTLV I/II Mixed Titer Performance Panel are the latest additions to […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Daniel O’Day, currently Chief Operating Officer (COO) of Roche Diagnostics has been appointed as COO of Roche Pharma effective September 1, 2012. He will succeed Pascal Soriot, who will leave Roche and take on new responsibilities outside the Group. Daniel O’Day will be succeeded by Roland […]
SALT LAKE CITY, – Idaho Technology, Inc., today announced it has changed the corporate name to BioFire Diagnostics, Inc. to more accurately reflect its business strategy and strong momentum in the marketplace. The Company has also re-launched its website (www.BioFireDx.com) to reveal its new branding. “We are excited to announce our new name to our […]
SANTA CLARA, Calif. & SINGAPORE — Affymetrix, Inc. (NASDAQ: AFFX) and PathGEN Dx Pte. Ltd., a spin-off molecular diagnostics company founded by researchers from the Genome Institute of Singapore, today announced they have signed a Powered by AffymetrixTM (PbA) Program agreement. Under this PbA agreement, PathGEN Dx will develop an in-vitro diagnostic kit for comprehensive […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced it has been awarded a $100,000 Small Business Technology Transfer Program (STTR) Phase I Grant by the National Institutes of Health’s National Center For Advancing Translational Sciences. This grant, entitled “Early Detection of Pancreatic Cancer Using ICE COLD-PCR”, is a joint project with Tony Hollingsworth, Ph.D., […]
NUSSLOCH, Germany and VISTA, Calif., — Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a leading provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, a leader in anatomical pathology solutions. Together, the two businesses will leverage each other’s strengths to grow and expand digital pathology […]
Konstanz, Germany – As of today, PrenaTest® is available in more than 70 qualified prenatal diagnostic practices and clinics in Germany, Austria, Liechtenstein and Switzerland. PrenaTest® is a highly accurate non-invasive genetic blood test which is intended for use among women with pregnancies at high risk for fetal aneuploidy, specifically to detect fetal trisomy 21. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
